Nexcyon Pharmaceuticals
Pharmaceuticals, Madison, Wisconsin, 53725, United States, 11-50 Employees
Who is NEXCYON PHARMACEUTICALS
Nexcyon is a closely held research-based pharmaceutical company that focuses on the discovery and acquisition of new technologies for the treatment of diseases in companion animals. Since...
Read More
-
Headquarters: Madison, Wisconsin, 53725, United States
-
Date Founded: 2008
-
Employees: 11-50
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
-
CEO:
Terrence Clark
Email
Phone
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 424210 |
Show More
Does something look wrong? Fix it. | View contact records from NEXCYON PHARMACEUTICALS
Nexcyon Pharmaceuticals Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Nexcyon Pharmaceuticals
Answer: Nexcyon Pharmaceuticals's headquarters are located at Madison, Wisconsin, 53725, United States
Answer: Nexcyon Pharmaceuticals's official website is https://nexcyon.com
Answer: Nexcyon Pharmaceuticals's revenue is Under $1 Million
Answer: Nexcyon Pharmaceuticals's SIC: 2834
Answer: Nexcyon Pharmaceuticals's NAICS: 424210
Answer: Nexcyon Pharmaceuticals has 11-50 employees
Answer: Nexcyon Pharmaceuticals is in Pharmaceuticals
Answer: Nexcyon Pharmaceuticals contact info: Phone number: Website: https://nexcyon.com
Answer: Nexcyon is a closely held research-based pharmaceutical company that focuses on the discovery and acquisition of new technologies for the treatment of diseases in companion animals. Since its founding, Nexcyon has developed several medicines that have been approved around the globe and commercialized through distribution agreements with other pharmaceutical companies. Nexcyon seeks to in-license small molecules, biopharmaceuticals, vaccines, or diagnostics for development, enter into joint ventures or co-marketing arrangements, or acquire companies that manufacture, develop, or market companion animal medicines. Nexcyon also seeks to acquire products that are in mid- to late-stage development, approved, or those being divested.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month